Application of AAV2-mediated bFGF gene therapy on survival of ischemic flaps: Effects of timing of gene transfer

Annals of Plastic Surgery

Volumn 62, Issue 1, 2009, Pages 87-91

  Liu, Paul Y ^a,f   Wang, Xiao Tian ^a   Xin, Ke Qin ^b   Chen, Chuan Hao ^c,d   Rieger Christ, Kimberley ^e   Summerhayes, Ian C ^e   Fang Wu, Ya ^d   Tang, Jin Bo ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c BENGBU MEDICAL COLLEGE   (China)

^d NANTONG UNIVERSITY   (China)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Flap survival; Gene therapy; Growth factors; Ischemic flap; Viral vectors

Indexed keywords

ADENOVIRUS VECTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GRAFT NECROSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OPERATION DURATION; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; SPRAGUE DAWLEY RAT; SURGICAL TECHNIQUE; TISSUE SECTION; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS VIABILITY;

ANIMALS; DEPENDOVIRUS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENE TRANSFER TECHNIQUES; ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; TIME FACTORS;

EID: 65949086586     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31817439fe     Document Type: Article

References (46)

1. Khouri RK, Upton J, Shaw WW. Prefabrication of composite free flaps through stage microvascular transfer: an experimental and clinical study. Plast Reconstr Surg. 1991;87:108-115.
2. Abbase EA, Shenaq SM, Spira M, et al. Prefabricated flaps: experimental and clinical review. Plast Reconstr Surg. 1995;96:1218-1225.
3. Komuro Y, Takato T, Yamada A, et al. Experimental study of prefabricated flaps using vein grafts. J Reconstr Microsurg. 1993;9:373-379.
4. Pang CY, Forrest CR, Morris SF. Pharmacological augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought. Ann Plast Surg. 1989;22:293-306.
5. Knight KR. Review of postoperative pharmacological infusion in ischemic skin flaps. Microsurgery. 1994;15:675-684.
6. Nall AV, Brownlee RE, Colvin CP, et al. Transforming growth factor /31 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg. 1996;122:171-177.
7. Kryger Z, Dogan T, Zhang F, et al. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg. 1999;43:172-178.
8. Ishiguro N, Yabe Y, Shimizu T, et al. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg. 1994;32:356-360.
9. Kryger Z, Zhang F, Dogan T, et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg. 2000;53:234-239.
10. Taub PJ, Marmur JD, Zhang WX, et al. Effect of time on the viability of ischemic skin flaps treated with vascular endothelial growth factor (VEGF) cDNA. J Reconstr Microsurg. 1998;14:387-390.
11. Lubiatowski P, Goldman CK, Gurunluoglu R, et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg. 2002;109:1986-1993.
12. O'Toole G, MacKenzie D, Lindeman R, et al. Vascular endothelial growth gene therapy in ischemic rat skin flaps. Br J Plast Surg. 2002;55:55-58.
13. Neumeister MW, Song YH, Mowlavi A, et al. Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracillis muscle. Microsurgery. 2001;21:58-62.
14. Gurunluoglu R, Ozer K, Skugor B, et al. Effect of transfection time on the survival of epigastric skin flaps pretreated with adnovirus encoding the VEGF gene. Ann Plast Surg. 2002;49:161-169.
15. Liu PY, Tong W, Liu K, et al. Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat. Wound Repair Regen. 2004;12:80-85.
16. Liu PY, Wang XT, Badiavas E, et al. Enhancement of ischemic flap survival by prefabrication with transfer of exogenous PDGF gene. J Reconstr Microsurg. 2005;21:273-279.
17. Brenner M. Gene transfer by adenovectors. Blood. 1999;94:3965-3967.
18. Chandler LA, Sosnowski BA. Gene therapy for cutaneous wounds. Wounds. 2004;14:23-37.
19. Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG) and IgM) to adeno-associated virus (AAV). J Med Virol. 1999;59:406-411.
20. Daly TM. Overview of adeno-associated viral vectors. Methods Mol Biol. 2004;246:157-165.
21. Schwarz EM. The adeno-associated virus vector for orthopedic gene therapy. Clin Orthop. 2000;379S:31-39.
22. Goater J, Muller R, Kollias G, et al. Empirical advantages of adeno-associated viral vectors in vivo gene therapy for arthritis. J Rheumatol. 2000;27:983-989.
23. Zacchigna S, Papa G, Antonini A, et al. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am J Pathol. 2005;167:981-991.
24. Wang XT, Liu PY, Xin KQ, et al. Tendon healing in vitro: bFGF gene transfer to tenocytes by adeno-associated viral vectors promotes expression of collagen genes. J Hand Surg (Am). 2005;30:1255-1261.
25. Zhu B, Cao Y, Xin KQ, et al. Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons. J Hand Surg (Am). 2006; 31:1652-1660.
26. Wang XT, Liu PY, Tang JB, et al. Tendon healing in vitro: adeno-associated virus-2 effectively transduces intrasynovial tenocytes with persistent expression of the transgene, but other serotypes do not. Plast Reconstr Surg. 2007;119:227-234.
27. Wang XT, Liu PY, Tang JB. PDGF gene therapy enhances expression of VEGF and bFGF genes and activates the NF-kB gene in signal pathways in ischemic flaps. Plast Reconstr Surg. 2006;117:129-137.
28. Antonini A, Zacchigna S, Papa G, et al. Improved survival of rat ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer. Microsurg. 2007;27:439-445.
29. Hengge UR, Mirmohammadsadegh A. Adeno-associated virus expresses transgenes in hair follicles and epidemis. Mol Ther. 2000;2:188-194.
30. Donahue BA, McArthur JG, Spratt SK, et al. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med. 1999;1:31-42.
31. Deodato B, Arsic N, Zentilin L, et al. Recombinant AAV vector encoding human VEGF 165 enhances wound healing. Gene Ther. 2002;9:777-785.
32. Descamps V, Blumenfeld N, Beuzard Y, et al. Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adeno-associated virus vector. Arch Dermatol. 1996;132:1207-1211.
33. Moldauer I, Velez I, Kuttler S. Upregulation of basic fibroblast growth factor in human periapical lesions. J Endod. 2006;32:408-411.
34. Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumors and blood. Lung Cancer. 2006;51:143-158.
35. Brenchley PE. Antagonising angiogenesis in rheumatoid arthritis. Ann Rheum Dis. 2001;60(suppl 3):71-74.
36. Yoshida S, Matsumoto K, Tomioka D, et al. Recombinant hepatocyte growth factor accelerates cutaneous wound healing in a diabetic mouse model. Growth Factors. 2004;22:111-119.
37. Fahmy RG, Dass CR, Sun LQ, et al. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med. 2003;9:1026-1032.
38. van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci. 2001;936:426-437.
39. Im MJ, Kim YS, Edwards RJ, et al. The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg. 1992;28:242-245.
40. Duffy FJ Jr, Maitz PK, Hergrueter CA, et al. Maximizing flap survival in a prefabrication model using exogenous and endogenous bFGF: a new approach. Microsurg. 1996;17:176-179.
41. Haws MJ, Erdman D, Bayati S, et al. Basic fibroblast growth factor induced angiogenesis and prefabricated flap survival. J Reconstr Microsurg. 2001;17: 39-42.
42. Rashid MA, Akita S, Razzaque MS, et al. Coadministration of basic fibroblast growth factor and sucrose octasulfate (sucralfate) facilitates the rat dorsal flap survival and viability. Plast Reconstr Surg. 1999;103:941-948.
43. Fujihara Y, Koyama H, Nishiyama N, et al. Gene transfer of bFGF to recipient bed improves survival of ischemic skin flap. Br J Plast Surg. 2005;58:511-517.
44. Roll C, Prantl L, Feser D, et al. Functional donor-site morbidity following (osteo-) fasciocutaneous parascapular flap transfer. Ann Plast Surg. 2007;59: 410-414.
45. Xie RG, Gu JH, Gong YP, et al. Medial sural artery perforator flap for repair of the hand. J Hand Surg. 2007;32E:512-517.
46. Booi DI, Debats IB, Boeckx WD, et al. Risk factors and blood flow in the free transverse rectus abdominis (TRAM) flap: smoking and high flap weight impair the free TRAM flap microcirculation. Ann Plast Surg. 2007;59:364-731.